Labcorp Holdings Inc
LH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$398.92 | Qbhbngs | Jqfbzbljb |
LabCorp Reaps Benefit of Delta Variant; We've Raised Our Fair Value Estimate
Business Strategy and Outlook
As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers bright prospects as healthcare moves toward reformed payment models, despite current Medicare headwinds.